ArticleThe Journal of infection2024

IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C.

Thomas R O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.